Evolent Health Inc Class A

19.73-0.4300-2.13%Vol 203.87K1Y Perf 219.74%
Apr 19th, 2021 14:07 DELAYED
BID19.70 ASK19.74
Open20.00 Previous Close20.16
Pre-Market- After-Market-
 - -%  - -
Target Price
23.50 
Analyst Rating
Strong Buy 1.44
Potential %
19.23 
Finscreener Ranking
★★★★     55.47
Insiders Trans % 3/6/12 mo.
-/-/-100 
Value Ranking
★★     47.80
Insiders Value % 3/6/12 mo.
-/-/-100 
Growth Ranking
★★     44.64
Insiders Shares Cnt. % 3/6/12 mo.
-/-/-100 
Income Ranking
 —    -
Market Cap1.70B 
Earnings Rating
Strong Buy
Price Range Ratio 52W %
84.71 
Earnings Date
6th May 2021

Today's Price Range

19.6120.22

52W Range

5.2222.35

5 Year PE Ratio Range

-12.803.30

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Buy
Performance
1 Week
-0.20%
1 Month
-5.00%
3 Months
14.09%
6 Months
77.93%
1 Year
219.74%
3 Years
22.18%
5 Years
81.29%
10 Years
-

TickerPriceChg.Chg.%
EVH19.73-0.4300-2.13
AAPL134.460.30000.22
GOOG2 300.732.97000.13
MSFT258.42-2.3200-0.89
XOM56.12-0.5400-0.95
WFC44.220.38000.87
JNJ162.250.01000.01
FB302.06-4.1200-1.35
GE13.38-0.0100-0.07
JPM153.22-0.0800-0.05
Financial StrengthValueIndustryS&P 500US Markets
1.20
1.40
0.34
0.58
-10.90
Leverage Ratio 2.10
ProfitabilityValueIndustryS&P 500US Markets
31.40
-52.80
-46.40
-38.30
-33.00
RevenueValueIndustryS&P 500US Markets
775.15M
9.00
30.23
47.89
Earnings HistoryEstimateReportedSurprise %
Q04 2020-0.10-0.0640.00
Q03 2020-0.13-0.0746.15
Q02 2020-0.17-0.0758.82
Q01 2020-0.20-0.195.00
Q04 2019-0.10-0.0820.00
Q03 2019-0.21-0.1623.81
Q02 2019-0.29-0.31-6.90
Q01 2019-0.40-0.385.00
Earnings Per EndEstimateRevision %Trend
3/2021 QR-0.1037.50Positive
6/2021 QR-0.0833.33Positive
12/2021 FY-0.3620.00Positive
12/2022 FY-0.1436.36Positive
Next Report Date6th May 2021
Estimated EPS Next Report-0.10
Estimates Count3
EPS Growth Next 5 Years %-
Volume Overview
Volume203.87K
Shares Outstanding86.09M
Trades Count2.50K
Dollar Volume21.01M
Avg. Volume570.03K
Avg. Weekly Volume337.27K
Avg. Monthly Volume499.04K
Avg. Quarterly Volume575.95K

Evolent Health Inc Class A (NYSE: EVH) stock closed at 20.16 per share at the end of the most recent trading day (a -2.23% change compared to the prior day closing price) with a volume of 273.95K shares and market capitalization of 1.70B. Is a component of indices and it is traded on NYSE exchange. The company belongs in the Healthcare Providers & Services industry, Healthcare sector and employs 2900 people. Evolent Health Inc Class A CEO is Seth Blackley.

The one-year performance of Evolent Health Inc Class A stock is 219.74%, while year-to-date (YTD) performance is 25.76%. EVH stock has a five-year performance of 81.29%. Its 52-week range is between 5.22 and 22.35, which gives EVH stock a 52-week price range ratio of 84.71%

Evolent Health Inc Class A currently has a PE ratio of -5.30, a price-to-book (PB) ratio of 2.80, a price-to-sale (PS) ratio of 2.24, a price to cashflow ratio of 170.30, a PEG ratio of 2.32, a ROA of -22.27%, a ROC of -41.58% and a ROE of -41.17%. The company’s profit margin is -33.00%, its EBITDA margin is -46.40%, and its revenue ttm is $775.15 Million , which makes it $9.00 revenue per share.

Of the last four earnings reports from Evolent Health Inc Class A, there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $-0.10 for the next earnings report. Evolent Health Inc Class A’s next earnings report date is 06th May 2021.

The consensus rating of Wall Street analysts for Evolent Health Inc Class A is Strong Buy (1.44), with a target price of $23.5, which is +19.23% compared to the current price. The earnings rating for Evolent Health Inc Class A stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Evolent Health Inc Class A has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Evolent Health Inc Class A has a Buy technical analysis rating based on Technical Indicators (ADX : 12.35, ATR14 : 0.98, CCI20 : 27.16, Chaikin Money Flow : -0.10, MACD : 0.38, Money Flow Index : 68.51, ROC : 0.80, RSI : 48.30, STOCH (14,3) : 46.69, STOCH RSI : 0.20, UO : 51.64, Williams %R : -53.31), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Evolent Health Inc Class A in the last 12-months were: Jonathan D. Weinberg (Sold 0 shares of value $-38 400 ), Jonathan D. Weinberg (Sold 10 000 shares of value $130 100 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
7 (77.78 %)
8 (88.89 %)
8 (88.89 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
2 (22.22 %)
1 (11.11 %)
1 (11.11 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.44
Strong Buy
1.22
Strong Buy
1.22

Evolent Health Inc Class A

Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. The company's reportable segments are Service segment which includes value-based care services, specialty care management services and comprehensive health plan administration services. and True Health segment consists of a commercial health plan it operates in New Mexico that focuses on small and large businesses. It generates a majority of its revenue from the Service segment.

CEO: Seth Blackley

Telephone: +1 571 389-6000

Address: 800 N. Glebe Road, Arlington 22203, VA, US

Number of employees: 2 900

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

67%33%

Bearish Bullish

56%44%

Bearish Bullish

65%35%

News

Stocktwits